The clinical information you need, at your fingertips.

Large real-world study finds LVEF recovery is common, yet repeat echocardiography and sustained guideline-directed therapy lag behind recommendations. . .

A potent alpha-2 agonist, medetomidine is emerging as a dangerous adulterant with rapid, severe withdrawal and limited response to standard therapies. . .

Phase 2 data suggest avatrombopag may reduce chemotherapy delays and dose reductions in GI cancer patients with persistent thrombocytopenia. . .

A survey shows less than half of adults know an mpox vaccine exists, and majorities are unsure or wrong about whether vaccines exist for syphilis, chlamydia, herpes, and HIV. . .

A small study supports combining bariatric surgery with GLP-1 medication as a long-term treatment strategy for severe obesity, rather than treating them as alternative approaches. . .

A structured, yearlong approach aims to reduce maternal cardiovascular risk after delivery. . .

Routine islet autoantibody screening identified 81% of children who later developed stage 3 type 1 diabetes. . .

Accelerated approval of bulevirtide marks a milestone for a rare but aggressive viral infection with no prior approved treatments. . .